Akina Pharmacy
FDA inspection history across 2 sites, 2016 to 2024
- 2
- Form 483s
- 1
- Warning letter
Every document, by year
- Warning letter
- Form 483
2016: one Form 483; 2022: one Form 483; 2024: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2016One Form 483, at C hantilly, Virginia.
- 2022–24One Form 483 and one warning letter, at Sterling, Virginia.
- 2022The longest 483 on file: 9 observations over 9 pages at Sterling, Virginia.
Cited most
Across all Akina Pharmacy observations on file
- FDCA 501(a)(2)(A)Insanitary conditions9
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.192Production record review1
- 21 CFR 211.198Complaint files1
- 21 CFR 211.22Responsibilities of quality control unit1
The complete Akina Pharmacy file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Sterling, Virginia
One warning letter and one Form 483 · 2022 to 2024 · 9 observations
Latest: Warning letter, Apr 12, 2024 →C hantilly, Virginia
One Form 483 · 2016 · 5 observations
Latest: Form 483, Aug 10, 2016 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-04-12 | Warning letter Warning letter | Sterling, Virginia | — | $99 |
| 2022-12-09 | 483 Form 483 | Sterling, Virginia | 9 | $99 |
| 2016-08-10 | 483 Form 483 | C hantilly, Virginia | 5 | $99 |
Investigators on these documents
Daniel J. Min (1)Jonathan G. Matrisciano (1)Tajah L. Blackburn (1)
FEI number 3012590153 · most recent document Apr 12, 2024
About Akina Pharmacy
How many FDA Form 483s has Akina Pharmacy received?
FDA Intel has 2 Form 483s on file for Akina Pharmacy; the most recent is dated Dec 9, 2022.
When was Akina Pharmacy last inspected by FDA?
The most recent FDA inspection document on file for Akina Pharmacy is a Form 483 dated Dec 9, 2022, for the site in Sterling, Virginia.
What did FDA cite at Akina Pharmacy?
The regulations cited most in the observations on file for Akina Pharmacy are FDCA 501(a)(2)(A) (Insanitary conditions), 9 times; 21 CFR 211.165 (Testing and release for distribution), 1 time; 21 CFR 211.192 (Production record review), 1 time.
Has Akina Pharmacy received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Akina Pharmacy; the most recent is dated Apr 12, 2024.